OV-1, sheep is an alpha-helical antimicrobial ovispirin peptide derived from SMAP29 peptide (sheep), which inhibits several antibiotic-resistant bacterial strains including mucoid and nonmucoid Pseudomonas aeruginosa.
OV-1, sheep is a peptide compound derived from ovine (sheep) sources, recognized for its defined amino acid sequence and utility in a range of biochemical and immunological research applications. As a synthetic or purified peptide, OV-1, sheep serves as a model antigen and reference standard in studies focused on immune recognition, antigen processing, and peptide-MHC interactions. Its well-characterized structure and origin make it a valuable tool for dissecting the molecular mechanisms underlying host-pathogen interactions, T-cell epitope mapping, and the development of peptide-based assays. The compound's relevance extends to both basic research and translational studies, where precise control over peptide identity and composition is critical for reproducible experimental outcomes.
Epitope mapping: OV-1, sheep is widely employed in the mapping of T-cell and B-cell epitopes due to its defined sequence and immunogenic properties. Researchers utilize this peptide to identify specific regions recognized by immune receptors, enabling detailed characterization of antigenic determinants. Such studies are essential for advancing the understanding of immune specificity, cross-reactivity, and the fundamental principles of antigen recognition in ovine models and related systems.
Immunoassay development: The peptide is frequently used as a standard or capture antigen in various immunoassay platforms, including enzyme-linked immunosorbent assays (ELISA) and radioimmunoassays (RIA). Its consistent biochemical profile supports the development of sensitive and specific assays for the detection of antibodies or cellular responses against ovine antigens. This application is particularly valuable in veterinary immunology and vaccine research, where reliable quantification of immune responses is necessary for experimental validation and quality control.
Peptide-MHC binding studies: OV-1, sheep serves as a model ligand in investigations of peptide binding to major histocompatibility complex (MHC) molecules. By incorporating the peptide into in vitro binding assays or structural studies, scientists can elucidate the molecular interactions that govern antigen presentation and T-cell activation. These findings contribute to the broader understanding of immune recognition mechanisms and inform the rational design of peptide-based immunogens or diagnostic reagents.
Synthetic peptide research: The compound is also utilized as a reference in studies focused on peptide synthesis, purification, and analytical characterization. Researchers use OV-1, sheep to optimize solid-phase peptide synthesis protocols, validate chromatographic methods, and assess peptide stability under various experimental conditions. Its defined structure facilitates method development and benchmarking in laboratories engaged in peptide chemistry and analytical biochemistry.
Antigen processing investigations: In studies of antigen processing and presentation, OV-1, sheep is introduced into cellular or in vitro systems to monitor proteolytic cleavage, peptide transport, and loading onto MHC molecules. These experiments provide insights into the pathways and molecular machinery responsible for generating immunogenic peptides from protein antigens. By enabling precise tracking of peptide fate, the compound supports research into immune surveillance, host defense, and the development of novel immunological tools.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More